World News

Leucine makes drug manufacturing compliance less onerous on October 16, 2023 at 11:00 am

Published

on

The compliance process at pharmaceutical manufacturers is a complicated and prone to errors because many still use paper-based systems to record manufacturing steps. These paper records are reviewed by FDA auditors to ensure that guidelines were followed, but they are prone to errors, often leading to warnings. This results in higher costs and slower manufacturing. […]

© 2023 TechCrunch. All rights reserved. For personal use only.

​ The compliance process at pharmaceutical manufacturers is a complicated and prone to errors because many still use paper-based systems to record manufacturing steps. These paper records are reviewed by FDA auditors to ensure that guidelines were followed, but they are prone to errors, often leading to warnings. This results in higher costs and slower manufacturing.
© 2023 TechCrunch. All rights reserved. For personal use only. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version